EFFECT OF LURASIDONE ON WEIGHT AND METABOLIC PARAMETERS: RESULTS FROM POOLED SHORT-TERM PLACEBO-CONTROLLED AND LONG-TERM EXTENSION TRIALS IN SCHIZOPHRENIA

被引：0
|
作者：
Pikalov, Andrei [1 ]
Cucchiaro, Josephine [1 ]
Ogasa, M. [1 ]
Silva, Robert [1 ]
Hsu, J. [1 ]
Xu, J. [1 ]
Loebel, Antony [1 ]
机构：
[1] Sunovion Inc, Ft Lee, NJ USA
来源：
SCHIZOPHRENIA BULLETIN | 2011年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [21] Efficacy and tolerability of lurasidone in schizophrenia: A systematic review and meta-analysis of short-term, randomized, placebo controlled trials
    Hagi, K.
    Nosaka, T.
    Kane, J.
    Correll, C.
    EUROPEAN PSYCHIATRY, 2021, 64 : S157 - S157
  • [22] Suicidal ideation and behavior in adults with major depressive disorder treated with vortioxetine: post hoc pooled analyses of randomized, placebo-controlled, short-term and open-label, long-term extension trials
    Mahableshwarkar, Atul R.
    Affinito, John
    Reines, Elin Heldbo
    Xu, Judith
    Nomikos, George
    Jacobsen, Paula L.
    CNS SPECTRUMS, 2020, 25 (03) : 352 - 362
  • [23] Weight change during long-term treatment with lurasidone: pooled analysis of studies in patients with schizophrenia
    Meyer, Jonathan M.
    Mao, Yongcai
    Pikalov, Andrei
    Cucchiaro, Josephine
    Loebel, Antony
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (06) : 342 - 350
  • [24] Efficacy and safety of selegiline transdermal system for atypical depression: pooled analysis of short-term placebo-controlled trials
    Patkar, A. A.
    Jang, S.
    Portland, K.
    Jung, S.
    Pae, C.
    Nelson, J. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S257 - S258
  • [25] Estimating long-term effects of treatment from placebo-controlled trials with an extension period, using virtual twins
    Vittinghoff, Eric
    McCulloch, Charles E.
    Woo, Claudine
    Cummings, Steven R.
    STATISTICS IN MEDICINE, 2010, 29 (10) : 1127 - 1136
  • [26] Short-term Weight Change and Long-term Mortality in the Trials of Hypertension Prevention
    Cook, Nancy R.
    Appel, Lawrence J.
    Whelton, Paul K.
    CIRCULATION, 2016, 133
  • [27] Validation of a novel method to predict long-term effects of treatment using short-term placebo controlled trials
    Shinoff, C. W.
    McCulloch, C. E.
    Cummings, S. R.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S147 - S147
  • [28] Efficacy and safety of lurasidone for schizophrenia: A systematic review and meta-analysis of eight short-term, randomized, double-blind, placebo-controlled clinical trials
    Gao, Shan
    Fan, Ling
    Yu, Zhigang
    Xie, Xingxing
    BIOMEDICAL REPORTS, 2024, 20 (06)
  • [29] EFFECT OF SHORT-TERM TREATMENT WITH LURASIDONE ON QUALITY OF LIFE IN SCHIZOPHRENIA: RESULTS FROM THE PEARL 3 TRIAL
    Silva, Robert
    Cucchiaro, Josephine
    Hsu, J.
    Sarkin, A.
    Loebel, Antony
    Marder, Stephen R.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 321 - 321
  • [30] Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials
    Sieper, Joachim
    Porter-Brown, Benjamin
    Thompson, Liz
    Harari, Olivier
    Dougados, Maxime
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 95 - 100
12345